NYSE$BLCO
Bausch + Lomb Corp · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Bausch + Lomb's second-quarter performance was characterized by double-digit total revenue growth across all segments, despite ongoing supply chain issues, and the advancement of plans to reshape the company.
Bausch + Lomb reported revenues of $1.035 billion, a 10% increase compared to the second quarter of 2022. The company experienced a GAAP Net Loss Attributable to Bausch + Lomb Corporation of $32 million. They raised their full-year revenue outlook and reaffirmed Adjusted EBITDA guidance range.
- Revenues of $1.035 Billion
- GAAP Net Loss Attributable to Bausch + Lomb Corporation of $32 Million
- Adjusted EBITDA (non-GAAP) of $179 Million
- Revenues Grew 10% as Reported and 12% on a Constant Currency Basis Compared to the Second Quarter of 2022, Driven by Growth Across All Segments
Headline financials
Revenue & EPS history
Bausch + Lomb · Revenue · Quarterly
$1.04B
Revenue by segment
Bausch + Lomb · $1.04B total across 3 segments · Q2 2023
- Vision Care$646M+9.7%62.4%
- Surgical$195M+6.0%18.8%
- Pharmaceuticals$194M+15.5%18.7%
Forward guidance
Bausch + Lomb raised its revenue guidance for the full year of 2023 and reaffirmed its Adjusted EBITDA (non-GAAP) guidance for the full year of 2023.
Tailwinds
- Full-Year revenue between $3.95 - $4.00 billion
- Full-year Adjusted EBITDA (non-GAAP) between $700 - $750 million
- ~6.5 - 7.5% constant currency growth
- Foreign exchange headwinds for the full year Revenue: ~$50 million
- Foreign exchange headwinds for the full year Adj. EBITDA (non-GAAP): ~$35 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2023
-1.0%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-1.0%
Avg return
30 days after
43%
9 / 21 earnings
Positive
+18.7%
Q4 2023
Best reaction
-15.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.8% | +2.9% | -1.0% | |
| Q4 2025 | +0.2% | +1.5% | -11.3% | |
| Q3 2025 | +2.1% | +0.3% | +6.5% | |
| Q1 2025 | -15.7% | -17.1% | -16.4% | |
| Q4 2024 | -0.3% | -3.3% | -4.8% | |
| Q3 2024 | -2.3% | -4.3% | -4.5% | |
| Q2 2024 | -0.1% | -8.7% | -2.6% | |
| Q1 2024 | -4.7% | -0.7% | +5.5% | |
| Q4 2023 | +18.7% | +15.7% | +10.8% | |
| Q3 2023 | +4.6% | +2.9% | -4.3% | |
| Q2 2023 | -2.5% | -3.4% | -7.2% | |
| Q1 2023 | +0.1% | +4.6% | +4.4% | |
| Q4 2020 | +0.4% | -3.7% | -14.1% | |
| Q4 2022 | +0.4% | -3.7% | -14.1% | |
| Q3 2022 | -4.9% | +5.6% | +7.9% | |
| Q3 2021 | -4.9% | +5.6% | +7.9% | |
| Q2 2022 | +4.7% | +6.3% | +1.2% | |
| Q2 2021 | +4.7% | +6.3% | +1.2% | |
| Q1 2022 | -6.8% | -14.6% | +5.0% | |
| Q4 2021 | -6.8% | -14.6% | +5.0% | |
| Q1 2021 | -6.8% | -14.6% | +5.0% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro